25+ Years Global Experience
Proven Track Record in M&A
Dynamic medical device executive with 25+ years driving commercialization of capital equipment and disposable medical devices across global markets
Founded and scaled multimillion-dollar company from inception through successful acquisition, demonstrating proven business-building capabilities
Extensive operational board experience with VC- and PE-backed companies, including strategic oversight and stakeholder engagement
Strategic oversight, fiduciary responsibility, risk management, and stakeholder engagement at Board of Directors level across multiple medical device companies
Extensive operational board experience at Entellus Medical, AngioScore, Spectranetics, Vector, EndoShape, Opsens Medical, and Argon Medical
Partnered with Venture Capital, Private Equity, and Investment Banking firms to raise capital, develop exit strategies, and execute M&A activities
Strategic oversight and stakeholder engagement
Capital equipment & disposable medical devices
KOL development & adoption strategies
M&A and strategic business expansion
CRM & BI analytics, compensation design
Building and scaling high-growth organizations
Signworld Business Partners (2023 – Present)
Teaching sales & marketing and AI classes to business owners in the Signworld Business Group. Helping prospective business owners transition to new business ownership.
Image 212° (2020–2023)
Founded and scaled one of the fastest-growing sign and graphics companies in the U.S., reaching $2.1M in revenue in three years, expanded customer base across 45 states, and successfully sold the business to Mello Marketing.
Argon Medical Devices (2018–2019)
Exceeded global sales plan by $3.4M, drove $12M YoY growth and >$77M in EBITDA, engaged Board of Directors on strategic initiatives, and reduced unwanted turnover by >50%.
Opsens Medical (2016–2018)
Recruited by the Board to lead U.S. commercialization efforts, developed strategy, upgraded team, achieved 3X monthly sales growth and 4X new customer base expansion, and enhanced KOL relationships.
Vector Corporation & EndoShape (2015–2016)
Led P&L and commercial strategy for two Volcano Capital portfolio companies, coordinated fundraising securing $6M Series F financing, and worked directly with Boards and bankers on acquisition discussions.
Spectranetics (2014)
Led 144-person commercial team, integrated two sales organizations post-acquisition, presented integration and strategy updates to the Board, and achieved 100% to plan in first quarter.
AngioScore (2012–2014)
Led global commercial team of 86 direct employees and 16 distributors delivering $60M revenue, engaged Board and bankers during successful $230M acquisition.
Abbott Vascular (2009–2012)
Managed $267M revenue division, 127-person team, and achieved market leadership after turnaround.
Entellus Medical (2008–2009)
Hired by VC and CEO to build commercial strategy and team for startup ENT company, exceeded disposable sales plan by 126% in early months.
Boston Scientific (1991–2008)
Advanced through senior leadership roles across Interventional Cardiology and Vascular Surgery, achieving #1 U.S. market share for multiple product lines and leading divisions exceeding $226M annual revenue. Leading Sales Director during the largest and fastest market share shift in medical device history (TAXUS DES Launch).
School of General Studies, Columbia, MO
Bachelor of General Studies: Marketing, Communications and Advertising
May 1986
Global medical device leadership
AngioScore successful exit
Customer base expansion
Richard P. Cassidy